日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness

更正：基于模型的皮下注射纳武利尤单抗替代给药策略以提高成本效益

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-026-01627-3
Wang, Yan; Bukkems, Laura H; Ter Heine, Rob; van Hasselt, J G C; Koolen, S L W; Hendrikx, J J M A; Van der Hulle, Tom; Kapiteijn, Ellen; Zwaveling, Juliette; Becker, Annemarie; van den Heuvel, Michel M; Theelen, Willemijn S M E; Oude Munnink, Thijs H; Smit, Egbert F; Guchelaar, Henk-Jan; Moes, Dirk Jan A R
发表日期：2026
文献求助 收藏

Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness

基于模型的皮下注射纳武利尤单抗替代给药策略以提高成本效益

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-025-01610-4
Wang, Yan; Bukkems, Laura H; Ter Heine, Rob; van Hasselt, J G C; Koolen, S L W; Hendrikx, J J M A; Van der Hulle, Tom; Kapiteijn, Ellen; Zwaveling, Juliette; Becker, Annemarie; van den Heuvel, Michel M; Theelen, Willemijn S M E; Oude Munnink, Thijs H; Smit, Egbert F; Guchelaar, Henk-Jan; Moes, Dirk Jan A R
发表日期：2026
文献求助 收藏

A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer

PHAROS 研究最新结果的简明语言摘要：恩考拉非尼联合比美替尼治疗 BRAF V600E 突变型转移性非小细胞肺癌患者

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2026.2645982
Johnson, Melissa L; Smit, Egbert F; Felip, Enriqueta; Ramalingam, Suresh S; Ahn, Myung-Ju; Tsao, Anne; Johnson, Bruce E; Offin, Michael; Hussein, Maen; Dagogo-Jack, Ibiayi; Goldman, Jonathan W; Clarke, Jeffrey M; Negrao, Marcelo V; Sanborn, Rachel E; Morgensztern, Daniel; Usari, Tiziana; Wilner, Keith; Alejandro, Linh; Rifi, Nada; Zhang, Xiaosong; Riely, Gregory J
肺癌
肿瘤
肿瘤免疫
BRAF
AROS
细胞生物学
发表日期：2026
文献求助 收藏

PATH-60. Advancing CNS tumor diagnostics with expanded DNA methylation-based classification

PATH-60：利用扩展的基于DNA甲基化的分类推进中枢神经系统肿瘤诊断

期刊:Cancer Cell
影响因子:44.5
doi:10.1016/j.ccell.2015.09.018
Best, Myron G; Sol, Nik; Kooi, Irsan; Tannous, Jihane; Westerman, Bart A; Rustenburg, François; Schellen, Pepijn; Verschueren, Heleen; Post, Edward; Koster, Jan; Ylstra, Bauke; Ameziane, Najim; Dorsman, Josephine; Smit, Egbert F; Verheul, Henk M; Noske, David P; Reijneveld, Jaap C; Nilsson, R Jonas A; Tannous, Bakhos A; Wesseling, Pieter; Wurdinger, Thomas; Sill, Martin; Schrimpf, Daniel; Patel, Areeba; Sturm, Dominik; Jäger, Natalie; Sievers, Philipp; Wick, Wolfgang; von Deimling, Andreas; Capper, David; Pfister, Stefan M; Jones, David T W; Sahm, Felix
肿瘤
表观遗传
肿瘤免疫
DNA甲基化
神经科学
发表日期：2025
文献求助 收藏

Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy

帕立妥单抗德鲁替康（HER3-DXd；MK-1022）用于铂类化疗和免疫治疗后的非小细胞肺癌

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-24-02744
Steuer, Conor E; Hayashi, Hidetoshi; Su, Wu-Chou; Nishio, Makoto; Johnson, Melissa L; Kim, Dong-Wan; Massarelli, Erminia; Felip, Enriqueta; Gold, Kathryn A; Murakami, Haruyasu; Baik, Christina S; Kim, Sang-We; Smit, Egbert F; Fujimura, Masahiro; Fan, Pang-Dian; Truchon, Karine; Su, Xin; Sternberg, David W; Jänne, Pasi A
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer

来自 PHAROS II 期研究的最新总生存期分析：恩考拉非尼联合比美替尼治疗 BRAF V600E 突变转移性非小细胞肺癌患者

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-02023
Johnson, Melissa L; Smit, Egbert F; Felip, Enriqueta; Ramalingam, Suresh S; Ahn, Myung-Ju; Tsao, Anne; Johnson, Bruce E; Offin, Michael; Hussein, Maen; Dagogo-Jack, Ibiayi; Goldman, Jonathan W; Clarke, Jeffrey M; Negrao, Marcelo V; Sanborn, Rachel E; Morgensztern, Daniel; Usari, Tiziana; Wilner, Keith; Alejandro, Linh; Rifi, Nada; Zhang, Xiaosong; Riely, Gregory J
肺癌
肿瘤
肿瘤免疫
BRAF
AROS
细胞生物学
发表日期：2025
文献求助 收藏

Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report

Encorafenib联合Binimetinib治疗BRAF V600E突变转移性非小细胞肺癌患者的II期PHAROS研究的最新疗效和安全性简报

期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1016/j.jtho.2025.05.023
Riely, Gregory J; Ahn, Myung-Ju; Clarke, Jeffrey M; Dagogo-Jack, Ibiayi; Esper, Raymond; Felip, Enriqueta; Gelsomino, Francesco; Goldman, Jonathan W; Hussein, Maen; Johnson, Melissa; Marrone, Kristen A; Morgensztern, Daniel; Nadal, Ernest; Negrao, Marcelo V; Offin, Michael; Provencio, Mariano; Ramalingam, Suresh S; Roof, Logan; Sanborn, Rachel E; Smit, Egbert F; Tsao, Anne; Usari, Tiziana; Alcasid, Ann; Wilner, Keith; Tonkovyd, Svitlana; Zhang, Xiaosong; Johnson, Bruce E
肺癌
肿瘤
肿瘤免疫
BRAF
AROS
细胞生物学
发表日期：2025
文献求助 收藏

TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study

TEIPP疫苗治疗免疫检查点耐药性非小细胞肺癌：一项首次人体I/II期剂量递增研究

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-60281-8
Emmers, Mitchell; Welters, Marij J P; Dietz, Michelle V; Santegoets, Saskia J; Boekesteijn, Sanne; Stolk, Anouk; Loof, Nikki M; Dumoulin, Daphne W; Geel, Annemarie L; Steinbusch, Lauri C; Valentijn, A Rob P M; Cohen, Danielle; de Miranda, Noel F C C; Smit, Egbert F; Gelderblom, Hans; van Hall, Thorbald; Aerts, Joachim G; van der Burg, Sjoerd H
肺癌
免疫/内分泌
肿瘤
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study

在晚期非小细胞肺癌中，帕博利珠单抗混合给药方案不劣于固定剂量方案：一项真实世界回顾性双中心队列研究

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-010065
Smeenk, Michiel M; van der Noort, Vincent; Hendrikx, Jeroen M A; Abedian Kalkhoran, Hanieh; Smit, Egbert F; Theelen, Willemijn S M E
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?

非小细胞肺癌免疫治疗耐药机制分类：我们如何才能做得更好？

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013110
van der Geest, Daphne; van Vliet, Alex; Peeper, Daniel S; Haanen, John B A G; Smit, Egbert F; Theelen, Willemijn S M E
肺癌
肿瘤
肿瘤免疫
治疗耐药
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏